-+ 0.00%
-+ 0.00%
-+ 0.00%

Propanc Biopharma implements 1-for-25 reverse stock split effective May 18

PUBT·05/14/2026 02:00:13
Listen to the news
Propanc Biopharma implements 1-for-25 reverse stock split effective May 18
  • Propanc Biopharma to execute 1-for-25 reverse stock split, effective before market open May 18, 2026.
  • Move targets Nasdaq $1 minimum bid requirement, supporting continued listing.
  • Outstanding shares expected to fall to about 2,278,372 from about 56,959,280 as of May 6, 2026.
  • Stock to continue trading under ticker PPCB.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Propanc Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605132200PRIMZONEFULLFEED9719240) on May 14, 2026, and is solely responsible for the information contained therein.